Prisma Health-upstate
Clinical trials sponsored by Prisma Health-upstate, explained in plain language.
-
Hand fracture study compares two fixation techniques
Disease control TerminatedThis study compared two ways to surgically fix unstable fractures in the long bones of the hand (metacarpals): using a buried wire inside the bone versus a plate and screws on the outside. The trial was stopped early after enrolling 25 adults. The goal was to see which method lea…
Phase: NA • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Cancer drug shows promise for rare gene mutation, but study halted early
Disease control TerminatedThis study tested a drug called tazemetostat in people with advanced solid tumors that have a specific gene change (ARID1A mutation). The drug works by blocking a protein that helps these tumors grow. The study aimed to see if the drug could shrink tumors or stop them from growin…
Phase: PHASE2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immunotherapy combo shows promise for rare cancers, but study halted early
Disease control TerminatedThis phase 2 trial tested a combination of two immunotherapy drugs, durvalumab and tremelimumab, in 92 people with advanced rare solid tumors who had no other standard treatment options. The goal was to see if the drugs could shrink tumors and to check for side effects. The study…
Phase: PHASE2 • Sponsor: Prisma Health-Upstate • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC